Minerva Neurosciences, Inc.
NERV
$3.33
$0.082.46%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -28.71% | -4.73% | |||
| Gross Profit | 28.71% | 4.73% | |||
| SG&A Expenses | -7.57% | -18.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.70% | -13.55% | |||
| Operating Income | 15.70% | 13.55% | |||
| Income Before Tax | 15.79% | 13.17% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 15.79% | 13.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.79% | 13.17% | |||
| EBIT | 15.70% | 13.55% | |||
| EBITDA | 15.71% | 13.55% | |||
| EPS Basic | 15.80% | 13.17% | |||
| Normalized Basic EPS | 15.79% | 13.17% | |||
| EPS Diluted | 15.80% | 13.17% | |||
| Normalized Diluted EPS | 15.79% | 13.17% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||